世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の創薬サービス市場

Global Drug Discovery Services Market

 

出版社 出版年月電子版価格
Verified Market Research
ヴェリファイドマーケットリサーチ
2020年2月US$3,950
シングルユーザライセンス

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは世界の創薬サービス市場を調査・分析したVerified Market Researchの市場調査報告書です。

Report Overview

The global Drug Discovery Servicesmarket was valued at 10.23 billion in 2019 and is projected to reach USD23.06 billion by 2027, growing at a CAGR of 11.54% from 2020 to 2027.
With increasing R&D Activities and demand for personalized medication, combined with technological advances in molecular sciences, the market is expected to grow all over the globe at a high CAGR.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Increasing spending in R&D
1.2 Growing Demand for Outsourcing Analytical Testing and Clinical Trial Services
1.3 Initiatives to cure rare disorders
1.4 Researches in Drug discovery
2. Market Restraints
2.1 High Drug discovery and development cost
2.2 Stringent Regulatory framework

Market Segmentation:
1. By Type:
1.1 Medicinal Chemistry
1.2 Biology Services
1.3 Drug Metabolism and Pharmacokinetics (DMPK)

2. By Process:
2.1 Target Selection
2.2 Target Validation
2.3 Hit-To-Lead Identification
2.4 Lead Optimization
2.5 Candidate Validation

3. By Drug Type:
3.1 Small Molecules
3.2 Biologics

4. By Therapeutic Area:
4.1 Oncology
4.2 Neurology
4.3 Cardiovascular Diseases
4.4 Respiratory Diseases
4.5 Diabetes
4.6 Other Therapeutic Areas

5. By Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific
2. Merck
3. GE Healthcare
4. Albany Molecular Research, Inc. (AMRI)
5. Charles River Laboratories International
6. Evotec
7. Pharmaceutical Product Development, LLC. (Ppd)
8. Jubilant Biosys
9. Covance
10. Genscript Biotech Corporation
11. Aurigene Discovery Technologies
12. Wuxi Apptec
13. Syngene
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Drug Discovery Servicesmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.



目次

1 INTRODUCTION OF GLOBAL DRUG DISCOVERY SERVICESMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL DRUG DISCOVERY SERVICESMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPE:
5.1 Medicinal Chemistry
5.2 Biology Services
5.3 Drug Metabolism and Pharmacokinetics (DMPK)

6 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY PROCESS:
6.1 Target Selection
6.2 Target Validation
6.3 Hit-To-Lead Identification
6.4 Lead Optimization
6.5 Candidate Validation

7 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE:
7.1 Small Molecules
7.2 Biologics

8 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA:
8.1 Oncology
8.2 Neurology
8.3 Cardiovascular Diseases
8.4 Respiratory Diseases
8.5 Diabetes
8.6 Other Therapeutic Areas

9 GLOBAL DRUG DISCOVERY SERVICESMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 ? 2025

10 GLOBAL DRUG DISCOVERY SERVICESMARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Thermo Fisher Scientific
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Merck
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 GE Healthcare
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Albany Molecular Research, Inc. (AMRI)
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Charles River Laboratories International
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Evotec
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Pharmaceutical Product Development, LLC. (Ppd)
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Jubilant Biosys
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Covance
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Development

11.10 Genscript Biotech Corporation
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Development

11.11 Aurigene Discovery Technologies
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Development

11.12 Wuxi Apptec
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Development

11.13 Syngene
11.13.1 Overview
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Development

12 Appendix
12.1 Related Reports

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る